chr1-54139617-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_201546.5(CDCP2):āc.1253A>Gā(p.His418Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,457,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_201546.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDCP2 | NM_001353655.3 | c.1117+136A>G | intron_variant | ENST00000530059.3 | NP_001340584.1 | |||
CDCP2 | NM_201546.5 | c.1253A>G | p.His418Arg | missense_variant | 4/4 | NP_963840.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDCP2 | ENST00000530059.3 | c.1117+136A>G | intron_variant | 5 | NM_001353655.3 | ENSP00000489959.1 | ||||
ENSG00000256407 | ENST00000637610.1 | n.*1281+136A>G | intron_variant | 5 | ENSP00000490901.1 | |||||
CDCP2 | ENST00000371330.1 | c.1253A>G | p.His418Arg | missense_variant | 4/4 | 2 | ENSP00000360381.1 | |||
ENSG00000280425 | ENST00000623663.2 | n.1606T>C | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250338Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135238
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1457430Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 724994
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at